RhumbLine Advisers’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $450K | Buy |
+37,649
| New | +$450K | ﹤0.01% | 2747 |
|
|
2024
Q3 | – | Sell |
-5,759
| Closed | -$31K | – | 4223 |
|
|
2024
Q2 | $31K | Sell |
5,759
-16,443
| -74% | -$88.6K | ﹤0.01% | 3799 |
|
|
2024
Q1 | $151K | Buy |
22,202
+1,110
| +5% | +$7.55K | ﹤0.01% | 3300 |
|
|
2023
Q4 | $143K | Sell |
21,092
-9,265
| -31% | -$62.9K | ﹤0.01% | 3333 |
|
|
2023
Q3 | $152K | Buy |
30,357
+2,126
| +8% | +$10.7K | ﹤0.01% | 3303 |
|
|
2023
Q2 | $204K | Buy |
+28,231
| New | +$204K | ﹤0.01% | 3234 |
|
|
2022
Q2 | – | Sell |
-17,681
| Closed | -$184K | – | 3119 |
|
|
2022
Q1 | $184K | Buy |
17,681
+4,862
| +38% | +$50.6K | ﹤0.01% | 2776 |
|
|
2021
Q4 | $144K | Sell |
12,819
-334
| -3% | -$3.75K | ﹤0.01% | 2893 |
|
|
2021
Q3 | $233K | Buy |
13,153
+1,249
| +10% | +$22.1K | ﹤0.01% | 2852 |
|
|
2021
Q2 | $227K | Buy |
+11,904
| New | +$227K | ﹤0.01% | 2892 |
|